AR030223A1 - RADIO-SIGNED PEPTIDIC ANALOG OF A VASOACTIVE INTESTINAL PEPTIDE, A METHOD FOR THEIR PRODUCTION, AND THE USE OF SUCH ANALOG FOR THE MANUFACTURE OF A DIAGNOSTIC AGENT - Google Patents
RADIO-SIGNED PEPTIDIC ANALOG OF A VASOACTIVE INTESTINAL PEPTIDE, A METHOD FOR THEIR PRODUCTION, AND THE USE OF SUCH ANALOG FOR THE MANUFACTURE OF A DIAGNOSTIC AGENTInfo
- Publication number
- AR030223A1 AR030223A1 ARP010102425A ARP010102425A AR030223A1 AR 030223 A1 AR030223 A1 AR 030223A1 AR P010102425 A ARP010102425 A AR P010102425A AR P010102425 A ARP010102425 A AR P010102425A AR 030223 A1 AR030223 A1 AR 030223A1
- Authority
- AR
- Argentina
- Prior art keywords
- peptide
- radio
- analog
- vasoactive intestinal
- vip
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Un análogo peptídico radiorotulador de un péptido intestinal vasoactivo que comprende un análogo de un péptido de adhesion al receptor del péptido intestinal vasoactivo (VIP) radiorotulado con un radionuclido donde dicho análogo peptídico de péptido intestinal vasoactivo tiene la secuencia His-Ser-Asp-Xxx-Val-4-Cl-D-Phe-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Fin-Leu-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2 (SEC.ID.NO:13) donde Xxx es Aib ácido a-amino isobutírico, Deg, a,a-di-etilglicina o Ae5e ácido 1-aminociclopentancarboxílico o una sal del mismo. Un método para producir un análogo peptídico vasoactivo radiorotulado para uso en sistemas de mamífero que comprende hacer reaccionar una sal de un radionuclido con un análogo de un péptido intestinal vasoactivo que tiene la secuencia (SEC. ID.No.:13) donde Xxx es Aib ácido a-amino isobutírico, Deg a,a-di-etilglicina o Ae5e ácido 1-aminociclopentancarboxílico en presencia de un agente reductor por un tiempo y bajo condiciones efectivas para producir el análogo peptídico radiorotulado. Uso de dichos análogos de péptido radiorotulado de VIP para la manufactura de un agente de radiodiagnostico para detectar la presencia de células que llevan el receptor del péptido intestinal vasoactivo (VIP) en un mamífero a) administrando un análogo del péptido radiorotulado de VIP durante un tiempo y bajo condiciones efectivas para alcanzar la union entre el análogo de péptido radiorotulado y dichas células que llevan el receptor VIP y b) determinando la distribucion del análogo del péptido radiorotulado durante un tiempo y bajo condiciones efectivas para obtener una imágen centellográfica de dicho mamífero.A radio-peptide peptide analog of a vasoactive intestinal peptide comprising an analog of a peptide adherent to the vasoactive intestinal peptide (VIP) receptor radio-labeled with a radionuclide wherein said vasoactive intestinal peptide peptide analogue has the His-Ser-Asp-Xxx sequence. Val-4-Cl-D-Phe-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Fin-Leu-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu- Asn-NH2 (SEQ ID NO: 13) where Xxx is Aib a-amino isobutyric acid, Deg, a, a-di-ethylglycine or Ae5e 1-aminocyclopentancarboxylic acid or a salt thereof. A method for producing a radioactive vasoactive peptide analog for use in mammalian systems comprising reacting a salt of a radionuclide with an analogue of a vasoactive intestinal peptide having the sequence (SEQ ID NO: 13) where Xxx is Aib a-amino isobutyric acid, Deg a, a-di-ethylglycine or Ae5e 1-aminocyclopentanecarboxylic acid in the presence of a reducing agent for a time and under effective conditions to produce the radio-labeled peptide analog. Use of said VIP radio-labeled peptide analogs for the manufacture of a radiodiagnostic agent to detect the presence of cells carrying the vasoactive intestinal peptide (VIP) receptor in a mammal a) by administering an analog of the VIP radio-labeled peptide for a time and under effective conditions to achieve the union between the radio-labeled peptide analogue and said cells bearing the VIP receptor and b) determining the distribution of the radio-labeled peptide analog over a period of time and under effective conditions to obtain a scintigraphic image of said mammal.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/629,632 US6608174B1 (en) | 2000-02-18 | 2000-07-31 | Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy |
Publications (1)
Publication Number | Publication Date |
---|---|
AR030223A1 true AR030223A1 (en) | 2003-08-13 |
Family
ID=37515842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010102425A AR030223A1 (en) | 2000-07-31 | 2001-05-22 | RADIO-SIGNED PEPTIDIC ANALOG OF A VASOACTIVE INTESTINAL PEPTIDE, A METHOD FOR THEIR PRODUCTION, AND THE USE OF SUCH ANALOG FOR THE MANUFACTURE OF A DIAGNOSTIC AGENT |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR030223A1 (en) |
MY (1) | MY129008A (en) |
TW (1) | TWI288751B (en) |
-
2001
- 2001-05-22 AR ARP010102425A patent/AR030223A1/en not_active Application Discontinuation
- 2001-05-24 MY MYPI20012470 patent/MY129008A/en unknown
- 2001-07-31 TW TW90118678A patent/TWI288751B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TWI288751B (en) | 2007-10-21 |
MY129008A (en) | 2007-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Niall et al. | Amino acid sequence of salmon ultimobranchial calcitonin | |
Maroux et al. | On the hydrophobic part of aminopeptidase and maltases which bind the enzyme to the intestinal brush border membrane | |
Du Vigneaud et al. | Synthesis of the pressor-antidiuretic hormone, arginine-vasopressin | |
ES524370A0 (en) | A METHOD OF PREPARING A PEPTIDE THAT INHIBITS THE RELEASE OF GONADOTROPINS BY THE PITUITARY GLAND IN MAMMALS | |
ES2044841T3 (en) | PROCEDURE FOR THE PREPARATION OF SYNTHETIC PEPTIDES WITH INTERLEUQUIN 1 HUMAN ACTIVITY. | |
ES458691A1 (en) | Polypeptide | |
Gilhuus-Moe et al. | The presence and possible role of phosphopantothenic acid in gramicidin S synthetase | |
DE69617440D1 (en) | ISOLATED NUCLEIC ACID MOLECULES, PEPTIDES COMPLEX WITH HLA-A2 MOLECULES (MHC), AND THEIR USE | |
IL105763A0 (en) | Clostridium perfringens vaccines | |
AR017510A1 (en) | ISOLATED OR RECOMBINANT POLYCUCLEOTIDE, EXPRESSION VECTOR, GUEST CELL, METHOD FOR PREPARING AN ANTIGEN POLYPEPTIDE, METHOD AND EQUIPMENT FOR LADETECTION OF A POLINUCLEOTIDE, UNION COMPOUND, METHOD OF EMPLOYMENT OF A COMPOSITE OPTIMETED SUBSTITUTE | |
Katsoyannis et al. | Insulin Peptides. XII. Human Insulin Generation by Combination of Synthetic A and B Chains1 | |
DK0775160T3 (en) | Cyclic hexapeptide somatostatin analogues | |
ES2157259T3 (en) | PROCEDURE TO PREPARE ESTERES OF AMINO ACIDS AND NUCLEOSID ANALOGS. | |
Bennett | Biosynthetic fate of the amino-terminal fragment of pro-opiomelanocortin within the intermediate lobe of the mouse pituitary | |
Saheki et al. | Peptide structures of pyruvate kinase isozymes: 1. Comparison of the four pyruvate kinase isozymes of the rat | |
AR030223A1 (en) | RADIO-SIGNED PEPTIDIC ANALOG OF A VASOACTIVE INTESTINAL PEPTIDE, A METHOD FOR THEIR PRODUCTION, AND THE USE OF SUCH ANALOG FOR THE MANUFACTURE OF A DIAGNOSTIC AGENT | |
ATE140958T1 (en) | AUTOANTIBODIES TO INCREASE CHEMICAL REACTION RATE | |
Wu et al. | Biogenesis of membrane lipoproteins in Escherichia coli | |
Loeble et al. | Characterization of the subunits of thymidylate synthetase | |
Barra et al. | Rohdei-litorin: a new peptide from the skin of Phyllomedusa rohdei | |
ES8801945A1 (en) | Monoclonal antibodies against atrial natriuretic peptides. | |
ATE47880T1 (en) | PRECURSOR OF A C-END AMIDATED PEPTIDE AND ITS PRODUCTION. | |
ARON et al. | Nonsomatostatin secretory peptide (s) derived from prosomatostatin's amino terminus in a rat medullary thyroid carcinoma cell line | |
ES8500219A1 (en) | Cyclic peptides with somatostatin activity. | |
Richter | Biosynthesis of vasopressin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |